http://www.youtube.com/watch?feature=player_embedded&v=oZjMMo_cunA
These product liability cases involve pancreatic cancer after the use of Byetta, Januvia, Janumet or Victoza as part of the “Incretin Mimetics Product Liability Litigation.”
Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
http://www.youtube.com/watch?feature=player_embedded&v=oZjMMo_cunA
These product liability cases involve pancreatic cancer after the use of Byetta, Januvia, Janumet or Victoza as part of the “Incretin Mimetics Product Liability Litigation.”
According to the New York Times, Toyota has decided to enter into a global settlement over sudden acceleration death and injury cases. The announcement comes two months after a Toyota Camry’s electronic throttle system was found to be defective by an Oklahoma jury.
The jury found that Toyota had acted with “reckless disregard,” despite reports of problems in the cars, and was liable for a crash in 2005 that killed one woman and injured another.Toyota Motor Corporation and lawyers pursuing claims alleging the company’s vehicles suddenly accelerated, causing deaths or injuries, will begin an “intensive settlement process” to resolve the lawsuits.
U.S. District Judge James V. Selna in Santa Ana, California, on Friday December 13, issued an order halting the suits after Toyota and the lawyers asked for time to try settling the cases. Selna was scheduled to hear the first trial in March of about 200 federal claims consolidated before him.
http://www.youtube.com/watch?v=Z8YkrwxghUo&feature=player_detailpage
Johnson & Johnson Settlement Details
Jurors in state court in Philadelphia found that Janssen failed to adequately warn doctors for Haley Powell, of the risks of Topamax before she gave birth to a son with a cleft lip.
Smith & Nephew recently issued a safety notice that indicates the Birmingham hip failure rate appears to be higher than 1%, which exceeds the rate established for quality standards according to the United Kingdom’s National Institute for Health and Clinical Excellence.
According to data collected since 2010 in the National Joint Registry of England and Wales, as well as the Australian Orthopaedic Associations National Joint Replacement Registry, the rate of Smith & Nephew Birmingham hip problems that were classified as a failure were 1.29% and 1.12%, respectively.
Johnson & Johnson Under Fire from Lawsuits
The settlement is the second multibillion-dollar settlement this month for J&J. The company, agreed November 4 to pay $2.2 billion to resolve criminal and civil probes into the marketing of Risperdal and other medicines.
http://www.youtube.com/watch?v=UrCdYKvJCl4&feature=player_detailpage
The proposed settlement is going to be presented in federal court and will need the blessing of the federal judge overseeing the DePuy ASR litigation, which at last count has passed the 12,000 mark for folks afflicted by the allegedly faulty hip implant.
http://www.youtube.com/watch?v=9XqN0hVm-Qg&feature=player_detailpage
Settlement Impacts Thousands of Patients
Robin Arnold and her husband, Felix, filed her case in the U.S. District Court for the Western District of Texas. They filed claims against Bard for negligence, failure to warn, design defects, manufacturing defects, breach of implied warranty, negligent misrepresentation and loss of consortium.
According to media experts in 2012, drug makers in the United States spent $3.47 billion on advertising directly to consumers. Abbott Laboratories spent $80 million advertising AndroGel last year. Sales of prescription testosterone gels that are absorbed through the skin generated over $2 billion in American sales last year.